skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: Base de dados/Biblioteca: Springer Journals remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Correction: NCAPD2 is a favorable predictor of prognostic and immunotherapeutic biomarker for multiple cancer types including lung cancer
Correction: NCAPD2 is a favorable predictor of prognostic and immunotherapeutic biomarker for multiple cancer types including lung cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Correction: NCAPD2 is a favorable predictor of prognostic and immunotherapeutic biomarker for multiple cancer types including lung cancer

Feng, Linyuan ; Yang, Yang ; Lin, Zhenhua ; Cui, Minghua ; Jin, Aihua ; Cui, Aili

Genes and environment, 2024-02, Vol.46 (1), p.6-6, Article 6 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
2
Correction to: miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy
Correction to: miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Correction to: miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy

Huang, Qian ; Xi, Jiajia ; Wang, Lei ; Wang, Xu ; Ma, Xiaodong ; Deng, Qipan ; Lu, Yong ; Kumar, Munish ; Zhou, Zhiyuan ; Li, Ling ; Zeng, Zhaoyang ; Young, Ken H ; Yi, Qing ; Zhang, Mingzhi ; Li, Yong

Journal of hematology and oncology, 2018-07, Vol.11 (1), p.90-90, Article 90 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
3
237 In vitro potency assays for immune checkpoint blockade using human primary cells, murine huGEMM immune cells and patient-derived tumor organoids
237 In vitro potency assays for immune checkpoint blockade using human primary cells, murine huGEMM immune cells and patient-derived tumor organoids
Material Type:
Artigo 		Adicionar ao Meu Espaço

237 In vitro potency assays for immune checkpoint blockade using human primary cells, murine huGEMM immune cells and patient-derived tumor organoids

Yan, Xuefei ; Zhang, Hongjuan ; Zhou, Jun ; Zheng, Jia ; Zhu, Shuang ; Zhang, Rui ; Zang, Mingfa ; An, Annie Xiaoyu ; Xu, Xiaoxi ; Wang, Shuzong ; Xu, Kevin Qijin ; Ouang, Davy Xuesong ; Li, Henry ; Huang, Yujun

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A254-A254 [Periódico revisado por pares]

London: BMJ Publishing Group LTD

Texto completo disponível

Citações Citado por
4
40 The orion™ platform from rarecyte® enables same-day 21-plex fluorescence tissue analysis
40 The orion™ platform from rarecyte® enables same-day 21-plex fluorescence tissue analysis
Material Type:
Artigo 		Adicionar ao Meu Espaço

40 The orion™ platform from rarecyte® enables same-day 21-plex fluorescence tissue analysis

Campton, Daniel ; Cooper, Jeremy ; Reese, Steven ; Teplitz, Kyla ; Werbin, Jeffrey ; Nordberg, Joshua ; Kaldjian, Eric ; George, Tad

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A41-A41 [Periódico revisado por pares]

London: BMJ Publishing Group LTD

Texto completo disponível

Citações Citado por
5
564 Potency-reduced and extended half-life IL12 heterodimeric Fc-fusions exhibit strong anti-tumor activity with potentially improved therapeutic index compared to native IL12 agents
564 Potency-reduced and extended half-life IL12 heterodimeric Fc-fusions exhibit strong anti-tumor activity with potentially improved therapeutic index compared to native IL12 agents
Material Type:
Artigo 		Adicionar ao Meu Espaço

564 Potency-reduced and extended half-life IL12 heterodimeric Fc-fusions exhibit strong anti-tumor activity with potentially improved therapeutic index compared to native IL12 agents

Bernett, Matthew ; Varma, Rajat ; Liu, Ke ; Bonzon, Christine ; Rashid, Rumana ; Rodriguez, Nicole ; Hassanzadeh-Kiabi, Nargess ; Ardila, Connie ; Chu, Seung ; Muchhal, Umesh ; Desjarlais, John

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A598-A598 [Periódico revisado por pares]

London: BMJ Publishing Group LTD

Texto completo disponível

Citações Citado por
6
814 MCLA-145 (CD137xPD-L1): a potent CD137 agonist and immune checkpoint inhibitor that that does not show signs of peripheral toxicity
814 MCLA-145 (CD137xPD-L1): a potent CD137 agonist and immune checkpoint inhibitor that that does not show signs of peripheral toxicity
Material Type:
Artigo 		Adicionar ao Meu Espaço

814 MCLA-145 (CD137xPD-L1): a potent CD137 agonist and immune checkpoint inhibitor that that does not show signs of peripheral toxicity

Bol, Kees ; Marissen, Wilfred ; Elaissais-Schaap, Jeroen ; Tacken, Paul ; Engels, Steef ; Wang, Liang-Chuan ; Mondal, Arpita ; Throsby, Mark ; Roberts, Alan ; Mayes, Patrick ; Geuijen, Cecile

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A863-A863 [Periódico revisado por pares]

London: BMJ Publishing Group LTD

Texto completo disponível

Citações Citado por
7
Abstract withdrawn
Abstract withdrawn
Material Type:
Artigo 		Adicionar ao Meu Espaço

Abstract withdrawn

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A471-A471 [Periódico revisado por pares]

London: BMJ Publishing Group LTD

Texto completo disponível

Citações Citado por
8
A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer
A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer

Sebastian, Martin ; Schröder, Andreas ; Scheel, Birgit ; Hong, Henoch S. ; Muth, Anke ; von Boehmer, Lotta ; Zippelius, Alfred ; Mayer, Frank ; Reck, Martin ; Atanackovic, Djordje ; Thomas, Michael ; Schneller, Folker ; Stöhlmacher, Jan ; Bernhard, Helga ; Gröschel, Andreas ; Lander, Thomas ; Probst, Jochen ; Strack, Tanja ; Wiegand, Volker ; Gnad-Vogt, Ulrike ; Kallen, Karl-Josef ; Hoerr, Ingmar ; von der Muelbe, Florian ; Fotin-Mleczek, Mariola ; Knuth, Alexander ; Koch, Sven D.

Cancer Immunology, Immunotherapy, 2019-05, Vol.68 (5), p.799-812 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

Citações Citado por
9
Current progress in NK cell biology and NK cell-based cancer immunotherapy
Current progress in NK cell biology and NK cell-based cancer immunotherapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Current progress in NK cell biology and NK cell-based cancer immunotherapy

Tarazona, Raquel ; Lopez-Sejas, Nelson ; Guerrero, Beatriz ; Hassouneh, Fakhri ; Valhondo, Isabel ; Pera, Alejandra ; Sanchez-Correa, Beatriz ; Pastor, Nieves ; Duran, Esther ; Alonso, Corona ; Solana, Rafael

Cancer Immunology, Immunotherapy, 2020-05, Vol.69 (5), p.879-899 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

Citações Citado por
10
Lessons learned from the blockade of immune checkpoints in cancer immunotherapy
Lessons learned from the blockade of immune checkpoints in cancer immunotherapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Lessons learned from the blockade of immune checkpoints in cancer immunotherapy

Li, Xiaolei ; Shao, Changshun ; Shi, Yufang ; Han, Weidong

Journal of hematology and oncology, 2018-02, Vol.11 (1), p.31-31, Article 31 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (39.427)
  2. Revistas revisadas por pares (34.490)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (40.021)
  2. Anais de Congresso  (36)
  3. Resenhas  (2)
  4. Web Resources  (1)
  5. Mais opções open sub menu

Assunto 

  1. Immunotherapy  (36.867)
  2. Science & Technology  (26.300)
  3. Life Sciences & Biomedicine  (26.009)
  4. Humans  (17.246)
  5. Oncology  (15.785)
  6. Tumors  (10.619)
  7. Cancer  (10.313)
  8. Medicine  (10.187)
  9. Medicine & Public Health  (9.988)
  10. Monoclonal Antibodies  (9.258)
  11. Immunology  (8.926)
  12. Patients  (8.332)
  13. Lymphocytes  (7.827)
  14. Female  (6.671)
  15. Metastasis  (6.477)
  16. Cancer Therapies  (6.454)
  17. Chemotherapy  (5.947)
  18. Antigens  (5.774)
  19. Animals  (5.760)
  20. Male  (5.154)
  21. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1972  (26)
  2. 1972Até1984  (263)
  3. 1985Até1997  (1.662)
  4. 1998Até2011  (4.483)
  5. Após 2011  (33.627)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (39.113)
  2. Japonês  (2.485)
  3. Alemão  (888)
  4. Francês  (61)
  5. Chinês  (20)
  6. Português  (20)
  7. Norueguês  (14)
  8. Italiano  (9)
  9. Russo  (6)
  10. Holandês  (6)
  11. Espanhol  (2)
  12. Romeno  (1)
  13. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.